Síndrome de Waardenburg. Variabilidad en una familia en Sandino, Pinar del Río, Cuba / Waardenburg syndrome: variability in a Sandino family

Authors

  • Fidel Castro Pérez Especialista de Segundo Grado en Otorrinolaringología. Profesor Auxiliar. Policlínico Dr. Ernesto Guevara de la Serna.
  • Yenia Ledesma Vega Especialista de Primer Grado en Genética Médica. Policlínico Dr. Ernesto Guevara de la Serna.
  • Carlos Ivis Otaño Placencia Especialista de Primer Grado en Medicina General Integral. Máster en Asesoramiento Genético. Policlínico Juan Navarro.
  • Pedro Antonio Ramírez Sosa Especialista de primer Grado en Medicina General Integral. Máster en Asesoramiento Genético. Instructor. Policlínico Dr. Ernesto Guevara de la Serna.
  • Milagros Ramos Cruz Especialista de Primer Grado en Otorrinolaringología. Profesor Auxiliar. Hospital Pediátrico Provincial Pepe Portilla.

Abstract

El síndrome de Waardenburg es una enfermedad infrecuente, autosómica y dominante que cursa con cierto grado de discapacidad cuando aparece la hipoacusia neurosensorial, sin embargo, se ha detectado en Sandino, Pinar del Río, Cuba, una familia con 26 individuos vivos portadores del síndrome. Se describe por primera vez el estudio general de la familia desde el primer portador, y se demuestra la variabilidad individual en los portadores.

DeCS: SÍNDROME DE WAARDENBURG/genética; SÍNDROME DE WAARDENBURG/fisiopatología; IRIS; SORDERA; Pigmentación.

ABSTRACT

Waardenburg Syndrome (WS) is a non-frequent autosomal dominant disease, showing a certain degree of disability when neurosensitive hypoacusia appears; however, in Sandino, Pinar de Río, Cuba a family, from whom 26 alive relatives show WS. The general study of this family from the first ill relative, and the individual variability is showed.

DeCS: Waardenburg syndrome/genetics; Waardenburg, syndrome/physiopathology; iris, deafness, pigmentation.

Downloads

Download data is not yet available.

References

1 - Síndrome de Waardenburg. Enciclopedia médica en español [monografía en internet]. 24 abril 2008. Disponible en: http://www.nlm.nih.gov/medlineplus/spanish/encyclopedia.html [Acceso 10 de marzo de 2011]

2. Dourmishev AL, Dourmmishev LA, Schwartz RA, Janniger CK. Waardenburg syndrome. Int J Dermatol. 1999; 38:656-63.

3. Reynolds JE, Meryer JM, Landa B, Stevens CA, Arnos KS, Israel J, et al. Analysis of variability of clinical manifestations in Waardenburg syndrome. Am J Med Genet. 1995; 57:540-7.

4. Pardono E, Van Bever Y, Van den Ende J, Havrenne PC, Iughetti P, Maestrelli S, et al. Waardenburg syndrome: clinical differentiation between types I and II. Am J Med Genet. 2003; 117A:223-5.

5. Shah K, Dalal SJ, Desai MP, Seth PN, Joshi NC, Ambani LM. White forelock, pigmentari disorder of irides, and long segment Hirschsprung disease: possible variant of Waardenburg syndrome. J Pediatr. 1981; 99; 432-5.

6. Abril Molina A, González Carretero A, Miras Baldó MJa, Narbona López E. Alteraciones de la pigmentación cutánea asociadas a obstrucción intestinal. Servicio de Neonatología. Hospital Clínico Universitario San Cecilio. Granada. España. An Pediatr (Barc). 2007[citado enero 2011]; 66:429-30. Disponible en: http://www.elsevier.es/en/node/2053372

7. Sznajer Y, Coldéa C, Meire F, Delierre I, Sekhara T, Touraine RL. A de novo XOS10 mutation causing severe type 4 Waardenburg suydrome without Hirschsprung disease. Amer J Hum Genet. 15 April 2008[citado enero 2011]; 146A (8): 1038-41. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.32247/full

8. arrer LA, Grundfast KM, Amos J, Arnos KS, Asher JH, Beighton P, Diehl SR, Fex J, Foy C, Friedman TB. et al. Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium. Amer J Hum Genet. 1992[citado enero 2011]; 50: 902-13. Disponible en: http://www.nih.gov

9. Tamayo ML, Gelvez N, Rodriguez M, Florez S, Varon C, Medina D, Bernal JE. Screening program for Waardenburg syndrome in Colombia: clinical definition and phenotypic variability. Amer J Hum Genet 15 Apr 2008[citado enero 2011]; 146A

(6): 1026-1031. Disponible en: http://http://www.ajmg.a.32189 [Acceso 04-04-2010]

10. Pardono E, Mazzeu JF, Lezirovitz K, Auricchio MT BM, Iughetti P, Nascimento RMP, Mingroni-Netto RC, Otto PA. Waardenburg Syndrome: Description of two novel mutations in the PAX3 gene, one of which incompletely penetrant. Genetic and Molecular Biology, 2006[citado enero 2011]; 29 (4): 601-04. Disponible en: http://www.scielo.br/pdf/gmb/v29n4/32106.pdf

11. Heller M, Guinle L, Airaudo C, Rodríguez EA. Vogt-Koyanagi-Harada syndrome: Association with alopecia areata. Sociedad Argentina de Dermatología [revista en internet]. 2007 [citado 10 marzo de 2011]; 14(2):193-4. Disponible en: http://sad.org.ar/revista/pdf/2007-2.pdf#page=31

12.Thapa R, Mallick D, Ghosh A, Ghosh A. Waardenburg syndrome associated with laryngomalacia. Singapore Medical Journal [revista em internet]. 2009 [citado 10 marzo de 2011]; 50(12):401. Disponible en: http://smj.sma.org.sg/5012/5012cr3.pdf

13. Tobin AM, Kirby B. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin. Br J Dermatol2005; 153 (2): 440-66.11-5. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.2005.06759.x/abstract

14. Adisen E, Oztas M, Gurer MA. Lack of efficacy of etanercept in acrodermatitis continua of Hallopeau. Int J Dermatol 2007[citado enero 2011]; 46 (11): 1205-07. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-4632.2007.03251.x/full

Downloads

Published

2011-07-01

How to Cite

1.
Castro Pérez F, Ledesma Vega Y, Otaño Placencia CI, Ramírez Sosa PA, Ramos Cruz M. Síndrome de Waardenburg. Variabilidad en una familia en Sandino, Pinar del Río, Cuba / Waardenburg syndrome: variability in a Sandino family. Rev Ciencias Médicas [Internet]. 2011 Jul. 1 [cited 2025 Aug. 29];15(2):204-1. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/771

Issue

Vol. 15 No. 2 (2011)

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/